LifeMD, Inc. (LFMDP) — 애널리스트 전망 / 애널리스트 컨센서스 목표가는. 기준 3 애널리스트 평가, 컨센서스는 강세 — 3 매수.
애널리스트 추정 주당순이익(EPS) $-0.55 및 매출 $0.21B 다음 회계연도.
주당순이익(EPS) 실적 추이: 2024: 실적 $-0.53 vs 추정 $-0.55 (상회 +4.1%). 2025: 실적 $-0.23 vs 추정 $-0.21 (하회 -8.1%). 애널리스트 정확도: 94%.
LFMDP 애널리스트 등급
Buy
최근 3개월 동안 LifeMD, Inc.에 주식 등급을 부여한 3명의 애널리스트 기준
EPS 전망 — LFMDP
94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.53
vs Est –$0.55
▲ 4.3% off
2025
Actual –$0.23
vs Est –$0.21
▼ 7.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
매출 전망 — LFMDP
88%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.212B
vs Est $0.206B
▲ 3.2% off
2025
Actual $0.194B
vs Est $0.234B
▼ 20.6% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
